Related Experiment Video
Updated: Jul 18, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
Immunological aspects of inhibitor development.
1Division of Hematology, Oncology and Transplantation, Hemophilia and Thrombosis Center, University of Minnesota, Minneapolis, MN, USA. redin002@umn.edu
Inhibitor antibodies are a serious complication of factor replacement therapy. Understanding the immune response to factor VIII (FVIII) and regulatory T-cells is key to preventing inhibitor formation in haemophilia.
Area of Science:
- Immunology
- Hematology
- Biochemistry
Background:
- Inhibitor antibodies are a significant complication of coagulation factor replacement therapy.
- Congenital and acquired haemophilia involve complex immune responses to factor VIII (FVIII).
Purpose of the Study:
- To elucidate the immune mechanisms underlying FVIII inhibitor formation.
- To explore the role of CD4+ T-cell subsets in immune tolerance and inhibitor development.
Main Methods:
- Analysis of immune responses to FVIII.
- Investigation of CD4+ T-cell subset interactions (Th1, Th2, Th3).
Main Results:
- The immune response to FVIII involves specific CD4+ T-cell subsets.
- Failure to activate regulatory CD4+ cells is implicated in FVIII inhibitor development.
Conclusions:
- Understanding T-cell dynamics is crucial for managing FVIII inhibitors.
- Further research is needed to apply these findings to immune tolerance and gene therapy for haemophilia.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Tumor Immunotherapy
Inhibitors of Virion Maturation and Assembly
Enzyme Inhibition
